author-photo

Fabienne Lebrun

Université libre de Bruxelles

26

Papers

2971

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From BOLERO-2

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (155)
Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer

2016 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (13)
Intracardiac Metastasis from Epitheloid Sarcoma: Rare Localization and Difficult Management

2014 Case Reports in Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Everolimus plus exemestane for hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer: overall survival results from BOLERO-2

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (354)
Phase II trial of oxaliplatin and 5-FU in patients (pts) with platinum-resistant recurrent (PRR) ovarian carcinoma (OVCA).

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer

2014 Oncologist
Show All
- Source
- Cite
- Save
Citations (18)
Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-Positive/HER2-Negative Breast Cancer

2014 Oncologist
Show All
- Source
- Cite
- Save
Citations (11)
Characterization of patients who received prior chemotherapy for advanced breast cancer (ABC) in BOLERO-2.

2013 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

2013 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (18)
Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial

2013 Cancer
Show All
- Source
- Cite
- Save
Citations (79)